Cargando…
A novel risk score system for prognostic evaluation in adenocarcinoma of the oesophagogastric junction: a large population study from the SEER database and our center
BACKGROUND: The incidence rate of adenocarcinoma of the oesophagogastric junction (AEG) has significantly increased over the past decades, with a steady increase in morbidity. The aim of this study was to explore a variety of clinical factors to judge the survival outcomes of AEG patients. METHODS:...
Autores principales: | Wang, Jun, Shi, Le, Chen, Jing, Wang, Beidi, Qi, Jia, Chen, Guofeng, Kang, Muxing, Zhang, Hang, Jin, Xiaoli, Huang, Yi, Zhao, Zhiqing, Chen, Jianfeng, Song, Bin, Chen, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278582/ https://www.ncbi.nlm.nih.gov/pubmed/34256714 http://dx.doi.org/10.1186/s12885-021-08558-1 |
Ejemplares similares
-
Prognostic Value of the Systemic Inflammation Response Index in Patients with Adenocarcinoma of the Oesophagogastric Junction: A Propensity Score-Matched Analysis
por: Chen, Yuan, et al.
Publicado: (2019) -
Establishment of prognostic models for adenocarcinoma of oesophagogastric junction patients with neoadjuvant chemoradiotherapy: a real-world study
por: Du, Rongxu, et al.
Publicado: (2022) -
Systemic chemotherapy for gastro-oesophagogastric junction adenocarcinoma and stomach adenocarcinoma in a metastatic setting
por: Sanjeevaiah, Aravind, et al.
Publicado: (2020) -
Dose-escalated neoadjuvant chemoradiotherapy for locally advanced oesophageal or oesophagogastric junctional adenocarcinoma
por: Duque-Santana, Victor, et al.
Publicado: (2022) -
Clinical importance of serum CEA and CA-19-9 levels in oesophagogastric junction adenocarcinomas
por: Sert, Ozlem Zeliha, et al.
Publicado: (2020)